Skip to content
Proposals to let decisions by other countries control American drug prices are illegal, would reduce the availability of innovative new treatments, and fail to […]
BIO warns MFN models are illegal, ineffective, and a threat to innovation Read More »
Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO
BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices Read More »
National Institutes of Health (NIH) Director Jay Bhattacharya acknowledged there are no studies indicating a link between any vaccine and autism as Senators pushed
NIH Director says no studies link vaccines and autism in hearing on modernization Read More »
The Biotechnology Innovation Organization (BIO) hailed inclusion of a bill to encourage new treatments for children with rare diseases and measures targeting reform of
BIO lauds passage of PPRV reauthorization and legislation on PBM reform Read More »
The Biotechnology Innovation Organization (BIO) warned that new changes in federal recommendations for the childhood vaccination schedule are unscientific and put children’s health at
BIO warns of risks from change to CDC’s vaccine recommendations Read More »
A researcher working in a university lab makes a discovery that could lead to a new cure. Investors who see the potential of the
Bayh-Dole at 45: Still an engine for innovation Read More »
Legislation to free up capital for small innovative firms by removing regulatory barriers for both companies and investors passed the House Dec. 11—a move
House passes BIO-backed legislation to increase access to capital Read More »
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are implementing policies designed to
BIO-CSBA report explains why and how states seek to attract biotech Read More »
At a time when the biopharma industry is seeking to increase U.S. manufacturing, Indiana is in the vanguard—and still expanding. During a Nov. 11
BIO on the American Road: Indiana, a production powerhouse, is still expanding Read More »
Venture capital funding for life sciences startups plummeted after legal changes weakened the patent system, according to new research that confirms the close relationship
Ahead of BIO IP Conference, research highlights why biotech needs strong patents Read More »
